Nesland JM - Search Results

1

Nuclear, cytoplasmic, and stromal expression of ZEB1 in squamous and small cell carcinoma of the esophagus.

Goscinski MA, Xu R, Zhou F, Wang J, Yang H, Huang R, Li Y, Larsen SG, Giercksky KE, Nesland JM, Suo Z. Goscinski MA, et al. Among authors: nesland jm. APMIS. 2015 Dec;123(12):1040-7. doi: 10.1111/apm.12473. APMIS. 2015. PMID: 26547370

2

Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China.

Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE. Goscinski MA, et al. Among authors: nesland jm. Oncology. 2008;75(1-2):49-59. doi: 10.1159/000151741. Epub 2008 Sep 12. Oncology. 2008. PMID: 18787344

3

Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines.

Goscinski MA, Suo ZH, Nesland JM, Flørenes VA, Giercksky KE. Goscinski MA, et al. Among authors: nesland jm. APMIS. 2008 Sep;116(9):823-31. doi: 10.1111/j.1600-0463.2008.01029.x. APMIS. 2008. PMID: 19024603

4

Primary tumor vascularity in esophagus cancer. CD34 and HIF1-α expression correlate with tumor progression.

Goscinski MA, Nesland JM, Giercksky KE, Dhakal HP. Goscinski MA, et al. Among authors: nesland jm. Histol Histopathol. 2013 Oct;28(10):1361-8. doi: 10.14670/HH-28.1361. Epub 2013 May 8. Histol Histopathol. 2013. PMID: 23653235

5

PDGFR-α and CD117 Expression Pattern in Esophageal Carcinomas.

Goscinski MA, Larsen SG, Giercksky KE, Nesland JM, Suo Z. Goscinski MA, et al. Among authors: nesland jm. Anticancer Res. 2015 Jul;35(7):3793-9. Anticancer Res. 2015. PMID: 26124324

6

Squamous cell carcinomas, an immunohistochemical and ultrastructural study.

Suo Z, Holm R, Nesland JM. Suo Z, et al. Among authors: nesland jm. Anticancer Res. 1992 Nov-Dec;12(6B):2025-31. Anticancer Res. 1992. PMID: 1284199

7

Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas.

Suo Z, Su W, Holm R, Nesland JM. Suo Z, et al. Among authors: nesland jm. Anticancer Res. 1995 Nov-Dec;15(6B):2797-8. Anticancer Res. 1995. PMID: 8669867

8

Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?

Goscinski MA, Larsen SG, Warloe T, Stoldt S, Nesland JM, Suo ZH, Giercksky KE. Goscinski MA, et al. Among authors: nesland jm. Scand J Surg. 2009;98(4):214-20. doi: 10.1177/145749690909800404. Scand J Surg. 2009. PMID: 20218417

9

FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions.

Goscinski MA, Suo Z, Flørenes VA, Vlatkovic L, Nesland JM, Giercksky KE. Goscinski MA, et al. Among authors: nesland jm. Ultrastruct Pathol. 2008 May-Jun;32(3):89-96. doi: 10.1080/01913120802034934. Ultrastruct Pathol. 2008. PMID: 18570153

10

Squamous cell carcinomas. An immunohistochemical study of cytokeratins and involucrin in primary and metastatic tumours.

Suo Z, Holm R, Nesland JM. Suo Z, et al. Among authors: nesland jm. Histopathology. 1993 Jul;23(1):45-54. doi: 10.1111/j.1365-2559.1993.tb01182.x. Histopathology. 1993. PMID: 7690007

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

546 results

Search Page